爱普塔集团 ATR
$142.50 −$1.54 (-1.07%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $142.50 0.00%
开盘$140.80
昨收$144.04
当日区间$139.52 – $142.83
成交量505.1K
市值$9.03B
市盈率（TTM）34.4
股息率1.35%
ATR 相关新闻
匹配 AptarGroup 或代码 ATR 的头条新闻，按最新排序。
- Wells Fargo Maintains AptarGroup(ATR.US) With Buy Rating, Raises Target Price to $155 正面
- BofA Securities Maintains AptarGroup(ATR.US) With Buy Rating, Maintains Target Price $172
- BofA Securities Maintains AptarGroup(ATR.US) With Buy Rating
- Analysts' Opinions Are Mixed on These Healthcare Stocks: AptarGroup (ATR) and Contineum Therapeutics, Inc. Class A (CTNM)
- William Blair Maintains AptarGroup(ATR.US) With Hold Rating
- Raymond James Maintains AptarGroup(ATR.US) With Buy Rating, Cuts Target Price to $160 负面
- BofA Securities Upgrades AptarGroup(ATR.US) to Buy Rating, Raises Target Price to $173 正面
- Astron Corp Ltd (Delisted): Application for quotation of securities - ATR
- Wells Fargo Maintains AptarGroup(ATR.US) With Buy Rating, Maintains Target Price $145
- Wells Fargo Maintains AptarGroup(ATR.US) With Buy Rating, Raises Target Price to $145 正面
- Astron Corp Ltd (Delisted): Application for quotation of securities - ATR
- BofA Securities Maintains AptarGroup(ATR.US) With Hold Rating, Cuts Target Price to $145 负面
- Astron Corp Ltd (Delisted): Application for quotation of securities - ATR
- CytoSorbents: Neutral Stance as U.S. DrugSorb-ATR Opportunity Offsets Near-Term Execution and Regulatory Risks
- Wells Fargo Upgrades AptarGroup(ATR.US) to Buy Rating, Raises Target Price to $144 正面
暂无评论——快来第一个聊聊 ATR。
登录后参与讨论。